COVID-19 VACCINE TECHNOLOGY ADAPTED TO DEVELOP FIRST MRNA DEFENSE AGAINST ANTIBIOTIC-RESISTANT BACTERIA

Summary from the TLDR newsletter

Israeli researchers have created an mRNA-based vaccine against Yersinia pestis, the bacterium that causes bubonic plague. The researchers hope the technology can be used to combat other lethal bacteria as well. When tested on animal models, the vaccine achieved 100% protection against pneumonic plague. The success of the study paves the way for a whole world of mRNA-based vaccines against other deadly bacteria.